Concept:
Prognostic factors for Renal Cell Carcinoma (RCC) are utilized to predict cancer-specific survival and recurrence. They are primarily derived from anatomical, histological, and clinical features of the tumor itself.
Explanation:
• The prognosis of RCC is heavily dependent on the tumor's biological aggressiveness and the extent of its spread at the time of diagnosis.
• Pathologic stage (which incorporates factors like tumor size, depth of invasion into Gerota's fascia, and involvement of the renal vein or IVC) is the single most powerful and universally accepted prognostic indicator.
• Nuclear grade (specifically the Fuhrman nuclear grading system or the updated WHO/ISUP grading system) is a highly validated histological prognostic factor. Tumors with a higher nuclear grade (marked pleomorphism and prominent nucleoli) exhibit much more aggressive behavior and poorer survival outcomes.
• Tumour site and size characteristics (such as whether the tumor invades the pelvicalyceal system or crosses anatomical compartments) influence the anatomical staging and thus directly impact the prognosis.
• Age (Option A), however, is generally excluded as an independent tumor-specific prognostic factor in validated RCC models (such as the SSIGN score or the UCLA Integrated Staging System). While an older patient may have a lower overall survival due to competing medical comorbidities, their age does not dictate the intrinsic biological aggressiveness or cancer-specific mortality of the RCC itself.
Final Answer:
Age is a demographic factor affecting overall survival but is not considered a primary tumor-specific prognostic factor for Renal Cell Carcinoma.